Cancer Vaccine Designer: Melanoma Neoantigen Trial

Conceptual demo based on The Economist report of a promising melanoma vaccine trial. All metrics are illustrative, not from the reported trial.

@media(min-width:900px){
@media(max-width:899px){
}

1. Select Mutations

2. Predicted Neoantigens

3. Vaccine Platform

Presets

@media(min-width:900px){
@media(max-width:899px){
}

Immune Cascade Simulation

Select mutations and press Run Trial
@media(min-width:900px){
@media(max-width:899px){
}

Trial Dashboard

Solid: treatment | Dashed: control | Shaded: 95% CI (illustrative)

Immune Monitoring

Mechanistic Summary

Exportable Trial Report

Super generates helpful tools and automates fact-checking across the internet proactively. If you enjoyed this tool, build your own with Super and share it with a friend.